Adverse Effects of GLP-1 Receptor Agonists - The Review of Diabetic Studies Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus MDPI Journal of Clinical Medicine Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials - Diabetes, Obesity and Metabolism Gastrointestinal adverse events of tirzepatide in the treatment of type 2 diabetes mellitus: A meta-analysis and trials sequential analysis - Medicine (Baltimore) Insights into the Mechanism of Action of Tirzepatide: A Narrative Review Springer Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis - Cureus Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide The Journal of Clinical Endocrinology & Metabolism Relationship between dietary fiber intake and chronic diarrhea in adults - World Journal of Clinical Cases

Hypercalcemia can cause nausea, vomiting, weakness, and frequent urination
Meghan Lafferty and Chuck Tomlinson provided library services and administrative support, respectively
As part of this scheme, SmartScripts has misappropriated almost $3 million that is rightfully due to Tiero. Court records show that in July 2024, SmartScripts agreed to a consent judgment requiring it to pay Tiero $3,052,575 to avoid the time and cost of litigation without admitting to any allegations. Last year, SmartScripts was sued in Missouri state court by KB Evans Drugs
The formula includes phospholipids from non-GMO sunflower lecithin and is vegan, non-GMO
Yoo S, Yoo ES, Kim JI, Sohn JW (2025) Exendin-4(1-32)K-Capric Acid, a Glucagon-Like Peptide-1 Receptor Agonist, Suppresses Food Intake via Arcuate Pro-Opiomelanocortin Neurons